Alkermes
ALKS
274 hedge funds and large institutions have $4.59B invested in Alkermes in 2022 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 87 increasing their positions, 86 reducing their positions, and 24 closing their positions.
142% more first-time investments, than exits
New positions opened: 58 | Existing positions closed: 24
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
49% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $8.46M
11% more funds holding
Funds holding: 246 → 274 (+28)
11% more capital invested
Capital invested by funds: $4.14B → $4.59B (+$443M)
1% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 86
2.08% less ownership
Funds ownership: 97.5% → 95.43% (-2.1%)
Top Buyers
Top Sellers
ALKS Hedge Fund Activity: Q2 2022 in Review
274 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Alkermes (ALKS) for Q2 2022, worth a combined $4.59B — up 11% from $4.14B a quarter earlier.
Buyers outnumbered sellers: 58 funds opened new ALKS positions and 24 closed out — a net gain of 34 holders — while 87 added to existing stakes and 86 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $54.6M. The largest seller was T. Rowe Price Associates, cutting an estimated $303M.
- 274 institutional investors held Alkermes (ALKS) as of Q2 2022, up from 246 in Q1 2022.
- Funds reported $4.59B of Alkermes stock for Q2 2022, up 11% quarter-over-quarter.
- 58 funds opened new Alkermes positions in Q2 2022 and 24 closed out, a net change of +34 holders.
- The largest Alkermes buyer in Q2 2022 was Lord, Abbett & Co, an estimated $54.6M added.
- The largest Alkermes seller in Q2 2022 was T. Rowe Price Associates, an estimated $303M sold.
Based on aggregated 13F filings for Q2 2022.